Role of the Fancg gene in protecting cells from particulate chromate-induced chromosome instability

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 626, Issue 1-2, 2007, Pages 120-127

  Savery, Laura C ^a   Grlickova Duzevik, Eliza ^a   Wise, Sandra S ^a   Thompson, W Douglas ^a   Hinz, John M ^b   Thompson, Larry H ^b   Wise Sr , John Pierce ^a  

^a UNIVERSITY OF SOUTHERN MAINE   (United States)

^b LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

Chromosome instability (CIN); FANCG; Fanconi anemia pathway; Hexavalent chromium (Cr(VI)); Lead chromate

Indexed keywords

CHROMIC ACID; FANCONI ANEMIA GROUP G PROTEIN; IRON;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CHO CELL; CHROMATID ABERRATION; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATION; CHROMOSOME DAMAGE; CONTROLLED STUDY; CYTOTOXICITY; DNA CROSS LINKING; FANCONI ANEMIA; FEMALE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CHO CELLS; CHROMATES; CHROMOSOMAL INSTABILITY; CRICETINAE; CRICETULUS; FANCONI ANEMIA COMPLEMENTATION GROUP G PROTEIN; HUMANS; LEAD; MUTAGENS;

CRICETULUS GRISEUS;

EID: 33845309627     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2006.09.005     Document Type: Article

References (42)

1. Wistuba I.I., Bryant D., Behrens C., Milchgrub S., Virmani A.K., Ashfaq R., Minna J.D., and Gazdar A.F. Comparison of features of human lung cancer cell lines and their corresponding tumors. Clin. Cancer Res. 5 (1999) 991-1000
2. IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans: Chromium, Nickel and Welding vol. 49 (1990), IARC, Lyons, France
3. Leonard A., and Lauwerys R.R. Carcinogenicity and mutagenicity of chromium. Mutat. Res. 76 (1980) 277-293
4. Levy L.S., and Vanitt S. Carcinogenicity and mutagenicity of chromium compounds: the association between bronchial metaplasia and neoplasia. Carcinogenesis 7 (1986) 831-835
5. Patierno S.R., Banh D., and Landolph J.R. Transformation of C3H/10T1/2 mouse embryo cells by insoluble lead chromate but not soluble calcium chromate relationship to mutagenesis and internalization of lead chromate particulates. Cancer Res. 47 (1988) 3815-3823
6. Characterization of Products Containing Lead and Cadmium in Municipal Solid Waste in the United States, 1970-2000, EPA/5S30-SW-015A (1989), US Environmental Protection Agency, Washington, DC
7. Smith C.J., Livingston S.D., and Doolittle D.J. An international literature survey of IARC group. I. Carcinogens reported in mainstream cigarette smoke. Food Chem. Toxicol. 35 (1997) 1107-1130
8. Occupational Exposure to Hexavalent Chromium; Final Rule, in: Federal Register: Rules, Regulations, Occupational Safety, Health Administration, vol. 71, no. 39, 2006, pp. 10099-10385.
9. Ishikawa Y., Nakagawa K., Satoh Y., Kitagawa T., Sugano H., Hirano T., and Tsuchiya E. Hot spots of chromium accumulation at bifurcations of chromate workers' bronchi. Cancer Res. 54 (1994) 2342-2346
10. Singh J., Pritchard D.E., Carlisle D.L., Mclean J.A., Montaser A., Orenstein J.M., and Patierno S.R. Internalization of carcinogenic lead chromate particles by cultured normal human lung epithelial cells: formation of intracellular lead-inclusion bodies and induction of apoptosis. Toxicol. Appl. Pharm. 161 (1999) 240-248
11. Wise S.S., Elmore L.W., Holt S.E., Little J.E., Bryant B.H., and Wise Sr. J.P. Telomerase-mediated lifespan extension of human bronchial cells does not affect hexavalent chromium-induced cytotoxicity or genotoxicity. Mol. Cell. Biochem. 255 (2004) 103-111
12. Wise Sr. J.P., Wise S.S., and Little J.E. The cytotoxicity and genotoxicity of particulate and soluble hexavalent chromium in human lung cells. Mutat. Res. 517 (2002) 221-229
13. Wise S.S., Holmes A.L., Ketterer M.E., Hartsock W.J., Fomchenko E., Katsifis S., Thompson W.D., and Wise Sr. J.P. Chromium is the proximate clastogenic species for lead chromate-induced clastogenicity in human bronchial cells. Mutat. Res. 560 (2004) 79-89
14. Wise J.P., Orenstein J.M., and Patierno S.R. Inhibition of lead chromate clastogenesis by ascorbate: relationship to particle dissolution and uptake. Carcinogenesis 14 (1993) 429-434
15. Wise Sr. J.P., Stearns D.M., Wetterhahn K.E., and Patierno S.R. Cell-enhanced dissolution of carcinogenic lead chromate particles: the role of individual dissolution products in clastogenesis. Carcinogenesis 15 (1994) 2249-2254
16. Xie H., Holmes A.L., Wise S.S., Gordon N., and Wise Sr. J.P. Lead chromate-induced chromosome damage requires extracellular dissolution to liberate chromium ions, but does not require particle internalization or intracellular dissolution. Chem. Res. Toxicol. 17 (2004) 1362-1367
17. Holmes A.L., Wise S.S., Xie H., Gordon N., Thompson W.D., and Wise Sr. J.P. Lead ions do not cause human lung cells to escape chromate-induced cytotoxicity. Toxicol. Appl. Pharmacol. 203 (2005) 167-176
18. Wise S.S., Holmes A.L., Moreland J.A., Xie H., Sandwick S.J., Stackpole M.M., Fomchenko E., Teufack S., May Jr. A.J., Katsfis S.P., and Wise Sr. J.P. Human lung cell growth is not stimulated by lead ions after lead chromate-induced genotoxicity. Mol. Cell. Biochem. 279 1/2 (2005) 75-84
19. Hirose T., Kondo K., Takahashi Y., Ishikura H., Fujino H., Tsuyuguchi M., Hashimoto M., Yokose T., Mukai K., Kodama T., and Monden Y. Frequent microsatellite instability in lung cancer from chromate-exposed workers. Mol. Carcinog. 33 (2002) 172-180
20. Grlickova-Duzevik E., Wise S.S., Munroe R.C., Thompson W.D., and Wise Sr. J.P. XRCC1 protects against particulate chromate-induced chromosome damage and cytotoxicity in Chinese hamster ovary cells. Toxicol. Sci. 92 2 (2006) 409-415
21. Masuda A., and Takahashi T. Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis. Oncogene 21 45 (2002) 6884-6897
22. Burds A.A., Lutum A.S., and Sorger P.K. Generating chromosome instability through the simultaneous deletion of Mad2 and p53. Proc. Natl. Acad. Sci. U.S.A. 102 32 (2005) 11296-11301
23. Wise J.P., Leonard J.C., and Patierno S.R. Clastogenicity of lead chromate particles in hamster and human cells. Mutat. Res. 278 (1992) 69-79
24. Xie H., Wise S.S., Holmes A.L., Xu B., Wakeman T.P., Pelsue S.C., Singh N.P., and Wise Sr. J.P. Carcinogenic lead chromate induces DNA double-strand breaks in human lung cells. Mutat. Res. 586 (2005) 160-172
25. Holmes A.L., Wise S.S., Sandwick S.J., Lingle W.L., Negron V.C., Thompson W.D., and Wise Sr. J.P. Chronic exposure to lead chromate causes centrosome abnormalities and aneuploidy in human lung cells. Cancer Res. 66 8 (2006) 4041-4048
26. Xu J., Bubley G.J., Detrick B., Blankenship L.J., and Patierno S.R. Chromium(VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA cross-links and S-phase blockade of cell cycle. Carcinogenesis 17 7 (1996) 1511-1517
27. Hussain S., Wilson J.B., Blom E., Thompson L.H., Sung P., Gordon S.M., Kupfer G.M., Joenje H., Mathew C.G., and Jones N.J. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2. DNA Repair 15 8 (2006) 875-884
28. Tebbs R.S., Hinz J.M., Yamada N.A., Wilson J.B., Salazar E.P., Thomas C.B., Jones I.M., Jones J.J., and Thompson L.H. New insights into the Fanconi anemia pathway from an isogenic FancG hamster CHO mutant. DNA Repair 4 (2005) 11-22
29. Thompson L.H., Hinz J.M., Yamada N.A., and Jones N.J. How Fanconi anemia proteins promote the four R's: replication, recombination, repair, and recovery. Environ. Mol. Mutagen. 45 (2005) 128-142
30. Thompson L.H., Fong S., and Brookman K. Validation of conditions for efficient detection of HPRT and APRT mutations in suspension-cultured Chinese hamster ovary cells. Mutat. Res. 74 1 (1980) 21-36
31. Griffin C.S. Aneuploidy, centrosome activity and chromosome instability in cells deficient in homologous recombination repair. Mutat. Res. 504 (2002) 149-155
32. Pellerin C., and Booker S.M. Reflections on hexavalent chrom: health hazards of an industrial heavyweight. Environ. Health Perspect. 108 9 (2000) A402-A407
33. Venkitaraman A.R. Tracing the network connecting BRCA and Fanconi anaemia proteins. Nat. Rev. Cancer 4 4 (2004) 266-276
34. J.M. Hinz, P.B. Nham, E.P. Salazar, L.H. Thompson, The Fanconi anemia pathway limits the severity of mutagenesis, DNA Repair, in press.
35. Alter B. Diagnostic evaluation of FA. In: Owen J., Frohnmayer L., and Eiler M.E. (Eds). Fanconi Anemia: Standards for Clinical Care. 2nd ed. (2003), Fanconi Anemia Research Fund Inc. 3-15
36. Meyer S., Barber L.M., White D.J., Will A.M., Birch J.M., Kohler J.A., Ersfeld K., Blom E., Joenje H., Eden T.O., and Malcolm Taylor G. Spectrum and significance of variants and mutations in the Fanconi anaemia group G gene in children with sporadic acute myeloid leukaemia. Br. J. Haematol. 133 3 (2006) 284-292
37. Vilcheck S.K., O'Brien T.J., Pritchard D.E., Ha L., Ceryak S., Fornsaglio J.L., and Patierno S.R. Fanconi anemia complementation group A cells are hypersensitive to chromium(VI)-induced toxicity. Environ. Health Perspect. 110 5 (2002) 773-777
38. O'Brien T., Xu J., and Patierno S.R. Effects of glutathione on chromium-induced DNA crosslinking and DNA polymerase arrest. Mol. Cell. Biochem. 222 (2001) 173-182
39. Rothfuss A., and Gompe M. Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol. Cell. Biol. 24 1 (2004) 123-134
40. Hussain S., Wilson J.B., Medhurst A.L., Hejna J., Witt E., Ananth S., Davies A., Masson J.Y., Moses R., West S.C., de Winter J.P., Ashworth A., Jones N.J., and Mathew C.G. Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. Hum. Mol. Genet. 13 12 (2004) 1241-1248
41. Caldecott K.W. XRCC1 and DNA strand break repair. DNA Repair 2 2 (2003) 955-969
42. Thompson L.H., and West M.G. XRCC1 keeps DNA from getting stranded. Mutat. Res. 459 1 (2000) 1-18